Aqr Capital Management LLC Clovis Oncology, Inc. Transaction History

Aqr Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$4.81 - $10.34 $75,444 - $162,182	-15,685 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.13 - $6.41 $64,779 - $100,540	15,685 New	15,685 $75,000
Q4 2018 Feb 14, 2019	SELL	$11.63 - $32.67 $458,140 - $1.29 Million	-39,393 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$42.06 - $62.4 $124,497 - $184,704	-2,960 Reduced 6.99%	39,393 $1.79 Million
Q1 2018 May 15, 2018	SELL	$50.12 - $67.72 $610,611 - $825,032	-12,183 Reduced 22.34%	42,353 $2.24 Million
Q4 2017 Feb 14, 2018	SELL	$57.69 - $84.58 $566,169 - $830,068	-9,814 Reduced 15.25%	54,536 $3.71 Million
Q3 2017 Nov 14, 2017	BUY	$67.17 - $84.81 $4.32 Million - $5.46 Million	64,350	64,350 $5.3 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.